JP2021533126A5 - - Google Patents
Info
- Publication number
- JP2021533126A5 JP2021533126A5 JP2021505674A JP2021505674A JP2021533126A5 JP 2021533126 A5 JP2021533126 A5 JP 2021533126A5 JP 2021505674 A JP2021505674 A JP 2021505674A JP 2021505674 A JP2021505674 A JP 2021505674A JP 2021533126 A5 JP2021533126 A5 JP 2021533126A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- product according
- raav
- mammal
- viral vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024001612A JP2024041871A (ja) | 2018-07-31 | 2024-01-10 | 臓器機能を制御するための遺伝子治療方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862712669P | 2018-07-31 | 2018-07-31 | |
| US62/712,669 | 2018-07-31 | ||
| PCT/US2019/044290 WO2020028466A1 (en) | 2018-07-31 | 2019-07-31 | Gene therapy methods to control organ function |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024001612A Division JP2024041871A (ja) | 2018-07-31 | 2024-01-10 | 臓器機能を制御するための遺伝子治療方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021533126A JP2021533126A (ja) | 2021-12-02 |
| JP2021533126A5 true JP2021533126A5 (enExample) | 2022-08-01 |
Family
ID=69230802
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021505674A Pending JP2021533126A (ja) | 2018-07-31 | 2019-07-31 | 臓器機能を制御するための遺伝子治療方法 |
| JP2024001612A Pending JP2024041871A (ja) | 2018-07-31 | 2024-01-10 | 臓器機能を制御するための遺伝子治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024001612A Pending JP2024041871A (ja) | 2018-07-31 | 2024-01-10 | 臓器機能を制御するための遺伝子治療方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20210301306A1 (enExample) |
| EP (1) | EP3829718A4 (enExample) |
| JP (2) | JP2021533126A (enExample) |
| KR (1) | KR20210052450A (enExample) |
| CN (1) | CN113301956B (enExample) |
| AU (1) | AU2019315445A1 (enExample) |
| BR (1) | BR112021001878A2 (enExample) |
| CA (1) | CA3108324A1 (enExample) |
| EA (1) | EA202190358A1 (enExample) |
| IL (1) | IL280531A (enExample) |
| MX (1) | MX2021001336A (enExample) |
| PH (1) | PH12021550243A1 (enExample) |
| SG (1) | SG11202101042SA (enExample) |
| WO (1) | WO2020028466A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150111918A1 (en) | 2012-03-08 | 2015-04-23 | Medtronic Ardian Luxembourg S.a.r.l | Immune system neuromodulation and associated systems and methods |
| EP3226795B1 (en) | 2014-12-03 | 2020-08-26 | Metavention, Inc. | Systems for modulating nerves or other tissue |
| US10524859B2 (en) | 2016-06-07 | 2020-01-07 | Metavention, Inc. | Therapeutic tissue modulation devices and methods |
| CN115707773A (zh) * | 2021-08-20 | 2023-02-21 | 中国科学院深圳先进技术研究院 | 一种利用交感神经控制血管内皮细胞异质性的方法 |
| WO2023019565A1 (zh) * | 2021-08-20 | 2023-02-23 | 中国科学院深圳先进技术研究院 | 一种利用交感神经控制血管内皮细胞异质性的方法 |
| CN116019909B (zh) * | 2022-09-16 | 2025-07-29 | 上海市第十人民医院 | 一种CRISPR/Cas9纳米系统 |
| CN116115758B (zh) * | 2022-11-22 | 2024-12-03 | 上海市内分泌代谢病研究所 | Gabaa受体作为靶点在制备或筛选降血脂、治疗肥胖和/或改善代谢的药物中的应用 |
| CN121313878A (zh) * | 2024-12-04 | 2026-01-13 | 良渚实验室 | 治疗帕金森病的化学遗传学基因治疗新方案 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US4863457A (en) | 1986-11-24 | 1989-09-05 | Lee David A | Drug delivery device |
| US5378475A (en) | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
| US5814618A (en) | 1993-06-14 | 1998-09-29 | Basf Aktiengesellschaft | Methods for regulating gene expression |
| US5464758A (en) | 1993-06-14 | 1995-11-07 | Gossen; Manfred | Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| US5443505A (en) | 1993-11-15 | 1995-08-22 | Oculex Pharmaceuticals, Inc. | Biocompatible ocular implants |
| US6342390B1 (en) | 1994-11-23 | 2002-01-29 | The United States Of America As Represented By The Secretary Of Health And Human Services | Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy |
| FR2814642B1 (fr) | 2000-10-03 | 2005-07-01 | Ass Pour Le Dev De La Rech En | Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee |
| US6723551B2 (en) | 2001-11-09 | 2004-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
| JP2009523006A (ja) * | 2004-05-07 | 2009-06-18 | アプレラ コーポレイション | 脈管疾患に関連する遺伝的多型、その検出方法および使用 |
| ES2525067T3 (es) * | 2005-04-07 | 2014-12-17 | The Trustees Of The University Of Pennsylvania | Método de incremento de la función de un vector de AAV |
| EP2561073B1 (en) * | 2010-04-23 | 2016-08-24 | University of Massachusetts | Cns targeting aav vectors and methods of use thereof |
| KR20150020250A (ko) * | 2012-06-19 | 2015-02-25 | 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 | 당뇨병을 치료하기 위한 조성물 및 방법 |
| GB201403684D0 (en) * | 2014-03-03 | 2014-04-16 | King S College London | Vector |
| EP3200830B1 (en) * | 2014-10-03 | 2020-09-09 | University of Massachusetts | High efficiency library-identified aav vectors |
| AU2016324317A1 (en) * | 2015-09-17 | 2018-03-08 | Coda Biotherapeutics, Inc. | Compositions and methods for treating neurological disorders |
| CA3011939A1 (en) * | 2016-02-02 | 2017-08-10 | University Of Massachusetts | Method to enhance the efficiency of systemic aav gene delivery to the central nervous system |
| US20170218842A1 (en) * | 2016-02-02 | 2017-08-03 | General Electric Company | Adjusting Airflow Distortion in Gas Turbine Engine |
| CA3014732A1 (en) * | 2016-03-09 | 2017-09-14 | Fadi ASSAF | Using dreadd for neuronal modulation in treating neuronal |
| MA44546B1 (fr) * | 2016-06-15 | 2021-03-31 | Univ California | Virus adéno-associés variants et procédés d'utilisation |
| WO2018008770A1 (ja) * | 2016-07-06 | 2018-01-11 | 国立研究開発法人国立循環器病研究センター | 末梢神経を操作する方法、脳および脊髄を除く臓器などにおいて神経細胞機能を変化させる機能を発生させる方法、および新規疾病の予防または治療方法、ならびに末梢神経投与用医薬 |
| MX2022004812A (es) * | 2019-10-22 | 2023-02-23 | Applied Genetic Tech Corporation | Sistemas de virus adeno-asociados (aav) para el tratamiento de enfermedades o trastornos neurodegenerativos asociados a la progranulina. |
-
2019
- 2019-07-31 KR KR1020217005554A patent/KR20210052450A/ko not_active Ceased
- 2019-07-31 WO PCT/US2019/044290 patent/WO2020028466A1/en not_active Ceased
- 2019-07-31 EA EA202190358A patent/EA202190358A1/ru unknown
- 2019-07-31 EP EP19845335.9A patent/EP3829718A4/en active Pending
- 2019-07-31 AU AU2019315445A patent/AU2019315445A1/en not_active Abandoned
- 2019-07-31 CN CN201980065036.9A patent/CN113301956B/zh active Active
- 2019-07-31 SG SG11202101042SA patent/SG11202101042SA/en unknown
- 2019-07-31 BR BR112021001878-6A patent/BR112021001878A2/pt unknown
- 2019-07-31 US US17/264,752 patent/US20210301306A1/en active Pending
- 2019-07-31 MX MX2021001336A patent/MX2021001336A/es unknown
- 2019-07-31 CA CA3108324A patent/CA3108324A1/en active Pending
- 2019-07-31 JP JP2021505674A patent/JP2021533126A/ja active Pending
-
2021
- 2021-01-31 IL IL280531A patent/IL280531A/en unknown
- 2021-02-01 PH PH12021550243A patent/PH12021550243A1/en unknown
-
2024
- 2024-01-10 JP JP2024001612A patent/JP2024041871A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021533126A5 (enExample) | ||
| Tan et al. | Projections of preBötzinger complex neurons in adult rats | |
| JP2015508760A5 (enExample) | ||
| US20140234275A1 (en) | Method for treating als via the increased production of factor h | |
| JP2021533126A (ja) | 臓器機能を制御するための遺伝子治療方法 | |
| WO2004111250A1 (ja) | アルツハイマー病の治療のための組換えアデノ随伴ウィルスベクター | |
| JP7229284B2 (ja) | グルカゴン類似ペプチド－１受容体亢進剤を含む筋減少症治療用薬学組成物 | |
| WO2021121166A1 (zh) | 用于癌症治疗的多靶向siRNA | |
| JP2019514902A (ja) | 経口投与用遺伝子伝達のためのナノ粒子およびこれを含む薬学組成物 | |
| Papa et al. | Nanovector-mediated drug delivery in spinal cord injury: a multitarget approach | |
| JP2011511090A5 (enExample) | ||
| CN108883186B (zh) | 序贯抗癌治疗 | |
| JP2015510889A (ja) | 中枢神経系障害を治療するための核酸ナノ粒子を中枢神経系へ送達する方法 | |
| US20220347321A1 (en) | Expression of neuropeptides | |
| Yuan et al. | Calcitonin gene‐related peptide antagonists in the treatment of episodic migraine | |
| CN112353940B (zh) | 一种用于预防或治疗抑郁症的药物及其应用 | |
| McCain | The future of gene therapy | |
| Burgain-Chain et al. | DNA electrotransfer: An effective tool for gene therapy | |
| CN116672435A (zh) | LRP1-β链短肽在治疗胰岛素抵抗和糖尿病中的应用 | |
| RS51481B (sr) | Lečenje amiotrofične lateralne skleroze | |
| Liu et al. | Non-viral gene delivery and therapeutics targeting to brain | |
| JPWO2018008770A1 (ja) | 末梢神経を操作する方法、脳および脊髄を除く臓器などにおいて神経細胞機能を変化させる機能を発生させる方法、および新規疾病の予防または治療方法、ならびに末梢神経投与用医薬 | |
| Bhagwat et al. | Neurogenesis: Gene-Based Strategies for Treating Ischemic Stroke | |
| Simonato et al. | Gene Therapy for Neurological Diseases | |
| Doyle | Delivering Genes to the Hypoglossal Motor System |